Literature DB >> 1989644

A novel detection system for submicroscopic human metastases in athymic mice.

B A McKenzie1, A Barrieux, N M Varki.   

Abstract

We developed a sensitive assay system to accurately detect the amount of human tumor DNA, if present, in athymic mouse organs. Genomic DNA was prepared from a human lung carcinoma cell line and from athymic mouse lungs (tumor-bearing and non-tumor bearing). Mixtures and dilutions of extracted DNA were slot-blotted onto nylon filters and probed with labeled, human-specific Alu sequences. The equivalent of one human cell per 2000 mouse cells could be detected using this assay. This sensitive assay may now be used to confirm the presence or absence of human neoplasm metastases in the athymic mouse model system.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1989644

Source DB:  PubMed          Journal:  Cancer Commun        ISSN: 0955-3541


  4 in total

1.  Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis.

Authors:  Lubor Borsig; Richard Wong; Richard O Hynes; Nissi M Varki; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

2.  P-selectin deficiency attenuates tumor growth and metastasis.

Authors:  Y J Kim; L Borsig; N M Varki; A Varki
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

3.  Quantification of human Alu sequences by real-time PCR--an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants.

Authors:  Tanja Schneider; Franz Osl; Thomas Friess; Hubertus Stockinger; Werner V Scheuer
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

4.  TRIzol and Alu qPCR-based quantification of metastatic seeding within the skeleton.

Authors:  J Preston Campbell; P Mulcrone; S K Masood; M Karolak; A Merkel; K Hebron; A Zijlstra; J Sterling; F Elefteriou
Journal:  Sci Rep       Date:  2015-08-14       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.